SYNTHESIS AND CHARACTERIZATION OF CYCLOHEXANE-1,3-DIONE DERIVATIVES AND THEIR IN SILICO AND IN VITRO STUDIES ON ANTIMICROBIAL AND BREAST CANCER ACTIVITY
Objective: The objective of this study was to evaluate in silico and in vitro anticancer activity for synthesized cyclohexane-1,3-dione derivatives.
Methods: The new series of cyclohexane-1,3-dione derivatives were synthesized based on the Michael addition reaction. Further, the structures of the synthesized compounds were confirmed by Fourier-transform infrared spectroscopy, 1H nuclear magnetic resonance (NMR), and 13C NMR spectral data. Then, the in silico molecular docking studies were carried out using AutoDock tool version 1.5.6 and AutoDock version 220.127.116.11 docking program. The antimicrobial activity was carried out using the agar disk diffusion method, and the in vitro anticancer activity was performed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay for the synthesized compound.
Results: In silico docking study, compound 5c showed good binding score and binding interactions with selected bacterial proteins and breast cancer protein. Further, compound (5a-5h) was tested for their antimicrobial activity and compound 5c was only tested for anticancer activity (human breast adenocarcinoma 3,4-methylenedioxyamphetamine-MB-231 cell line). Compound 5c was found to be the most active one of all the tested compounds. In the MTT assay compound, 5c showed the LC50 value of 10.31±0.003 μg/ml. In antimicrobial activity, the minimum inhibitory concentration of compound 5c is 2.5 mg/ml.
Conclusion: An efficient synthesis of biologically active cyclohexane-1, 3-dione derivatives has been developed.
2. Mendes N, Tortosa F, Valente A, Marques F, Matos A, Morais TS, et al. In vivo performance of a ruthenium-cyclopentadienyl compound in an orthotopic triple negative breast cancer model. Anticancer Agents Med Chem 2017;17:126-36.
3. Harun SNA, Israf DA, Tham CL, Lam KW, Cheema MS, Md Hashim NF, et al. The molecular targets and anti-invasive effects of 2,6-bis-(4-hydroxyl-3methoxybenzylidine) cyclohexanone or BHMC in MDA-MB-231 human breast cancer cells. Molecules 2018;23. pii: E865.
4. Küçükgüzel ?G, ?enkarde? S. Recent advances in bioactive pyrazoles. Eur J Med Chem 2015;97:786-815.
5. Kumar V, Kaur K, Gupta GK, Sharma AK. Pyrazole containing natural products: Synthetic preview and biological significance. Eur J Med Chem 2013;69:735-53.
6. Claisen L, Claparede A. Condensation von ketonen mit aldehyden. Ber Dtsch Chemischen Ges 1881;14:2460-8.
7. Alwash AH, Mahdi AM, Al-Karagully HJ. Synthesis, characterization, and antimicrobial evaluation of new N-phenylcinnamamide derivatives linked to aspirin and ibuprofen. Asian J Pharm Clin Res 2018;11:443-6.
8. Umadevi A, Kumari C, Ajith Kumar P, Hameemath Shaman Nasmin AM, Divya K, Hisana PV. Development and evaluation of polyherbal gel for antifungal activity. Int J Curr Pharm Res 2018;10:40-3.
9. Trost BM, Fleming I. Comprehensive Organic Synthesis. Vol. 1-9. New York, USA: Pergamon Press; 1991.
10. Basavaiah D, Rao AJ, Satyanarayana T. Recent advances in the Baylis-Hillman reaction and applications. Chem Rev 2003;103:811-92.
11. Sammelson RE, Kurth MJ. Carbon-carbon bond-forming solid-phase reactions. Part II. Chem Rev 2001;101:137-202.
12. Huddleston RR, Krische MJ. Enones as latent enolates in catalytic processes: Catalytic cycloreduction, cycloaddition, and cycloisomerization. Synlett 2003;6:12-21.
13. Gibson SE, Stevenazzi A. The pauson-khand reaction: The catalytic age is here! Angew Chem Int Ed Engl 2003;42:1800-10.
14. Moreno-Mañas M, Pleixats R. Formation of carbon – carbon bonds under catalysis by transition-metal nanoparticles. Acc Chem Res 2003;36:638-43.
15. Asiri AM. Synthesis and characterization of dyes exemplified by 2-arylidene-1-dicyanomethyleneindane. Dyes Pigm 1999;42:209-13.
16. Ballini R, Bosica G. Nitroaldol reaction in aqueous media: An important improvement of the henry reaction. J Org Chem 1997;62:425-7.
17. Tang Z, Yang ZH, Chen XH, Cun LF, Mi AQ, Jiang YZ, et al. A highly efficient organocatalyst for direct aldol reactions of ketones with aldehydes [corrected]. J Am Chem Soc 2005;127:9285-9.
18. Chi Y, Gellman SH. Diphenylprolinol methyl ether: A highly enantioselective catalyst for Michael addition of aldehydes to simple enones. Org Lett 2005;7:4253-6.
19. Liu Y, Liu X, Wang M, He P, Lin L, Feng X, et al. Enantioselective synthesis of 3,4-dihydropyran derivatives via organocatalytic michael reaction of ?,?-unsaturated enones. J Org Chem 2012;77:4136-42.
20. Tiwary BK, Pathak RK, Pradhan K, Nanda AK, Bothra AK, Chakraborty R. Evaluation of drug candidature of some quinazoline-4-(3H)-ones as an inhibitor of human dihydrofolate reductase enzyme: Molecular docking and in silico studies. Int J Pharm Pharm Sci 2014;6 Suppl 20:393-400.
21. Wang SH, Wang XS, Da-Qing SH, Shu-Jiang TU. Michael addition reaction of dimedone and chalcone catalysed by KF/Al2O3. Chin J Org Chem 2003;23:1146-8.
22. Chinnamanayakar R, Ezhilarasi MR, Prabha B, Kulandhaivel M. In vitro Antimicrobial activity and in silico activity of 1-thiocarbamoyl substituted pyrazole derivatives. Asian J Chem 2018;30:783-9.
23. Sri Dharani R, Ranjitha R, Sripathi R, Ali Muhammad KS, Ravi S. Docking studies in target proteins involved in antibacterial action mechanisms: Alkaloids isolated from Scutellaria genus. Asian J Pharm Clin Res 2016;9:121-5.
24. Talarico LB, Zibetti RG, Faria PC, Scolaro LA, Duarte ME, Noseda MD, et al. Anti-herpes simplex virus activity of sulfated galactans from the red seaweeds Gymnogongrus griffithsiae and Cryptonemia crenulata. Int J Biol Macromol 2004;34:63-71.
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.